Compounds > deferoxamine

deferoxamine and daunorubicin

deferoxamine has been researched along with daunorubicin in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's2 (25.00)18.2507
2000's1 (12.50)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ellis, AL; Gewirtz, DA; Randolph, JK; Woods, KE1
Cohen, A; Estrov, Z; Freedman, MH; Gelfand, EW1
Cohen, A; Dubé, ID; Estrov, Z; Freedman, MH; Gelfand, EW; Sulh, H; Tawa, A; Wang, XH1
Cenas, N; Dickancaite, E; Kalvelyte, A; Serapiniene, N1
Elliott, RL; Head, JF; Wang, F1
Richardson, DR; Sutak, R; Xu, X1

Reviews

1 review(s) available for deferoxamine and daunorubicin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

7 other study(ies) available for deferoxamine and daunorubicin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Enhanced sensitivity of the rat hepatoma cell to the daunorubicin analogue 4-demethoxydaunorubicin associated with induction of DNA damage.
    Cancer research, 1989, Sep-01, Volume: 49, Issue:17

    Topics: Animals; Cell Division; Cell Membrane; Daunorubicin; Deferoxamine; DNA Damage; DNA, Neoplasm; Doxorubicin; Drug Screening Assays, Antitumor; Free Radicals; Idarubicin; Liver Neoplasms, Experimental; Rats; Tumor Cells, Cultured

1989
Synergistic antiproliferative effects on HL-60 cells: deferoxamine enhances cytosine arabinoside, methotrexate, and daunorubicin cytotoxicity.
    The American journal of pediatric hematology/oncology, 1988,Winter, Volume: 10, Issue:4

    Topics: Antimetabolites, Antineoplastic; Cell Line; Cytarabine; Daunorubicin; Deferoxamine; Dose-Response Relationship, Drug; Drug Synergism; Humans; Leukemia, Promyelocytic, Acute; Methotrexate; Tumor Cells, Cultured

1988
In vitro and in vivo effects of deferoxamine in neonatal acute leukemia.
    Blood, 1987, Volume: 69, Issue:3

    Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Cell Differentiation; Cell Division; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Cytarabine; Daunorubicin; Deferoxamine; Drug Resistance; Female; Humans; Indoles; Infant, Newborn; Leukemia, Lymphoid; Prednisone; Translocation, Genetic; Vincristine

1987
Toxicity of daunorubicin and naphthoquinones to HL-60 cells: an involvement of oxidative stress.
    Biochemistry and molecular biology international, 1997, Volume: 41, Issue:5

    Topics: Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Benzoquinones; Cell Survival; Daunorubicin; Deferoxamine; HL-60 Cells; Humans; Iron Chelating Agents; Naphthoquinones; Oxidative Stress; Phenylenediamines

1997
Antineoplastic drugs that interfere with iron metabolism in cancer cells.
    Advances in enzyme regulation, 1997, Volume: 37

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Cisplatin; Clinical Trials as Topic; Daunorubicin; Deferoxamine; Female; Gallium; Humans; Indium; Iron; Rats; Transferrin; Tumor Cells, Cultured

1997
Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking.
    Molecular pharmacology, 2008, Volume: 73, Issue:3

    Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cell Survival; Daunorubicin; Deferoxamine; Dose-Response Relationship, Drug; Doxorubicin; Embryo, Mammalian; Epirubicin; Fibroblasts; Gene Expression Regulation; Humans; Intracellular Signaling Peptides and Proteins; Iron; Iron Chelating Agents; Kinetics; Mice; Mice, Knockout; Molecular Structure; Myocytes, Cardiac; Protein Binding; Protein Transport; Receptors, Transferrin; RNA, Messenger; Siderophores

2008